Cover Image

Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort

Experimental studies suggest a role for osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in mammary tumor development and progression. These biomarkers have been minimally investigated with respect to outcomes in breast cancer patients.

Saved in:
Bibliographic Details
Main Authors: Le Cornet, Charlotte (Author) , Jung, Audrey Y. (Author) , Johnson, Theron S. (Author) , Behrens, Sabine (Author) , Obi, Nadia (Author) , Becher, Heiko (Author) , Chang-Claude, Jenny (Author) , Turzanski Fortner, Renée (Author)
Format: Article (Journal)
Language:English
Published: 17 April 2023
In: Breast cancer research
Year: 2023, Volume: 25, Pages: 1-10
ISSN:1465-542X
DOI:10.1186/s13058-023-01625-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13058-023-01625-4
Get full text
Author Notes:Charlotte Le Cornet, Audrey Y. Jung, Theron S. Johnson, Sabine Behrens, Nadia Obi, Heiko Becher, Jenny Chang-Claude and Renée T. Fortner
Description
Summary:Experimental studies suggest a role for osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in mammary tumor development and progression. These biomarkers have been minimally investigated with respect to outcomes in breast cancer patients.
Item Description:Gesehen am 19.05.2023
Physical Description:Online Resource
ISSN:1465-542X
DOI:10.1186/s13058-023-01625-4

Similar Items